Protara Therapeutics Inc
General ticker "TARA" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $103.9M
Protara Therapeutics Inc follows the US Stock Market performance with the rate: 7.0%.
Estimated limits based on current volatility of 23.4%: low 5.03$, high 5.37$
Factors to consider:
- Current price 46.6% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [1.30$, 3.51$]
- 2024-12-30 to 2025-12-30 estimated range: [1.51$, 3.83$]
Financial Metrics affecting the TARA estimates:
- Negative: Non-GAAP EPS, $ of -3.57 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Operating cash flow per share per price, % of -67.77 <= 2.35
Short-term TARA quotes
Long-term TARA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $47.49MM | $67.06MM | $43.61MM |
| Operating Income | $-47.49MM | $-67.06MM | $-43.61MM |
| Non-Operating Income | $0.24MM | $1.11MM | $3.19MM |
| R&D Expense | $21.09MM | $16.81MM | $24.99MM |
| Income(Loss) | $-47.25MM | $-65.95MM | $-40.42MM |
| Profit(Loss) | $-47.25MM | $-65.95MM | $-40.42MM |
| Stockholders Equity | $161.91MM | $102.08MM | $68.32MM |
| Inventory | $1.22MM | $1.16MM | $0.00MM |
| Assets | $172.60MM | $113.29MM | $78.95MM |
| Operating Cash Flow | $-34.50MM | $-26.46MM | $-37.56MM |
| Capital expenditure | $0.60MM | $0.12MM | $0.04MM |
| Investing Cash Flow | $-98.19MM | $14.95MM | $53.11MM |
| Financing Cash Flow | $-0.23MM | $-0.09MM | $-0.09MM |
| Earnings Per Share* | $-4.20 | $-5.76 | $-3.57 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.